Department of Bioengineering, University of California, Los Angeles, CA 90095, USA.
David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA.
Theranostics. 2018 Jan 1;8(3):815-829. doi: 10.7150/thno.19577. eCollection 2018.
Understanding the contribution of vascular cells to blood vessel remodeling is critical for the development of new therapeutic approaches to cure cardiovascular diseases (CVDs) and regenerate blood vessels. Recent findings suggest that neointimal formation and atherosclerotic lesions involve not only inflammatory cells, endothelial cells, and smooth muscle cells, but also several types of stem cells or progenitors in arterial walls and the circulation. Some of these stem cells also participate in the remodeling of vascular grafts, microvessel regeneration, and formation of fibrotic tissue around biomaterial implants. Here we review the recent findings on how adult stem cells participate in CVD development and regeneration as well as the current state of clinical trials in the field, which may lead to new approaches for cardiovascular therapies and tissue engineering.
了解血管细胞对血管重构的贡献对于开发治疗心血管疾病 (CVDs) 和再生血管的新治疗方法至关重要。最近的研究结果表明,内膜形成和动脉粥样硬化病变不仅涉及炎症细胞、内皮细胞和平滑肌细胞,还涉及动脉壁和循环中的几种类型的干细胞或祖细胞。其中一些干细胞还参与血管移植物的重塑、微血管再生以及生物材料植入物周围纤维组织的形成。在这里,我们综述了最近关于成体干细胞如何参与 CVD 发生和再生的研究结果,以及该领域的临床试验现状,这可能为心血管治疗和组织工程带来新的方法。